PDX Portal

Model Details

Patient Information for Model: BCM-PDAC-13

Model Contact

Model: BCM-PDAC-13
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email: qizhiyao@bcm.edu

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: BCM-PDAC-13

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: BCM-PDAC-13

There are no histology images for this model.

Metastasis Information for Model: BCM-PDAC-13

Patient

PDX

Liver

Local recurrence

Lung

Rectum

lymph node

Patient Treatment Information for Model: BCM-PDAC-13

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Pathologic Response	Reason Stopped
5	Gemcitabine/Abraxane	Neoadjuvant	64.9	65.09	69 days	Stable Disease (SD); CA 19-9 dropped from 504-184	No Response (NR)	Treatment Completed
15	Gemcitabine/Abraxane	Adjuvant	65.46	65.48	7 days			Poor performance status